November 28, 2025 – Dubai, UAE: INK PharmaSolutions, a global partner to the pharmaceutical, biotech, and healthcare industries, has announced its launch in the UAE with support from AstroLabs, the Gulf’s leading business expansion platform. Located at the Dubai Multi Commodities Centre (DMCC), the company’s new office strengthens its growing presence in the UAE and the wider MENA region.
With offices in Canada and now the UAE, INK PharmaSolutions operates across North America, Europe, the Middle East, and India, helping healthcare organizations navigate complex market landscapes. The company focuses on enabling global healthcare partnerships, expanding patient access through Patient Support Programs, and supporting market entry and commercialization for AI, software, pharmaceutical, medical device, and healthcare technology companies seeking international growth.
“Our expansion into Dubai’s DMCC marks a milestone in INK PharmaSolutions FZCO’s global journey,” said Daanyaal Bandukwala, Founder and Managing Director. “From our base in Canada to our new presence in the UAE, our focus remains the same: helping healthcare and life sciences organizations grow through strategy, commercialization, and cross-border partnerships.”
Nicole Serena, Founder and Managing Director, added: “This launch represents an important step toward creating a more connected healthcare ecosystem. Through INK PharmaSolutions FZCO, we aim to bridge markets, foster meaningful collaboration, and enable organizations to scale their solutions globally with both speed and precision. It’s about combining strategic expertise with real-world execution to deliver impact where it matters most.”
The UAE is becoming an increasingly pivotal hub in the Middle East’s pharmaceutical and healthcare ecosystem, with its pharma manufacturing, biotech, and digital health sectors at the forefront of national economic development.
Market reports indicate that the UAE healthcare ecosystem was valued at $ 34 billion in FY24 and is projected to expand at an approximate CAGR of 8% over the next five years. As the healthcare industry continues to transform, the demand for specialized healthcare consulting services focusing on niche areas of growth is on the rise.
“With a track record of driving strategic growth, a seasoned team, and rising regional demand, INK PharmaSolutions is well positioned to support healthcare companies on their journey to expand and scale their solutions across the UAE, the region, and beyond—helping shape a more connected and innovative healthcare ecosystem while contributing to the country’s socio-economic growth,” said Alex Nicolls, Director of Expansion at AstroLabs.
The firm’s new hub will enable it to strengthen partnerships and provide localized support to organizations pursuing international growth while navigating the region’s unique operational environment.
By setting up operations in the UAE, INK PharmaSolutions is poised to deliver substantial value for its partners by leveraging its extensive network and technical expertise, while significantly influencing the future of healthcare delivery across the region.
About INK PharmaSolutions FZCO
INK PharmaSolutions FZCO is a global partner to the pharmaceutical, biotech, and healthcare industries. We specialize in consulting, commercialization, and distribution strategy, helping organizations navigate complex market environments and connect innovation to impact. With offices in Canada and the UAE, we operate across North America, Europe, the Middle East, and India, enabling global healthcare partnerships, advancing access through Patient Support Programs, and supporting market entry and commercialization for AI, software, pharmaceutical, medical device, and healthcare technology firms seeking to expand internationally.
About AstroLabs
AstroLabs is the leading business expansion platform in the Gulf, supporting high-growth companies to set up, operate, and achieve full market integration in Saudi Arabia and the UAE.
With over a decade of experience and a network of 10,000+ decision-makers, we’ve helped 1,800+ companies successfully enter, scale, and embed themselves within the region’s fastest-growing economies.
In partnership with government entities across Saudi Arabia and key global markets, we run strategic programs that accelerate market access, build foundational industries, and support regional visions like Saudi Vision 2030.